Amino acid transfer across human placenta has been studied in an in vitro perfusion system. Transfer rates from maternal to fetal circuit of 12 amino acids were about the same when there was a downhill gradient permitting diffusion and active transport. This was termed "maximal transfer rate." Cystine, aspartic acid, and glutamic acid were transferred a t approximately half the rate of the others under these conditions. Measurement of exchange rates with radioactive tracers and with equimolar concentration of amino acids on both sides of the membrane provided a close estimate of maximal transfer rate. Fetal nutrition requires active transfer against a gradient. The rate of active transfer is a fraction of the exchange rate.
Summary
Amino acid transfer across human placenta has been studied in an in vitro perfusion system. Transfer rates from maternal to fetal circuit of 12 amino acids were about the same when there was a downhill gradient permitting diffusion and active transport. This was termed "maximal transfer rate." Cystine, aspartic acid, and glutamic acid were transferred a t approximately half the rate of the others under these conditions. Measurement of exchange rates with radioactive tracers and with equimolar concentration of amino acids on both sides of the membrane provided a close estimate of maximal transfer rate. Fetal nutrition requires active transfer against a gradient. The rate of active transfer is a fraction of the exchange rate.
The ability to establish a transplacental gradient by perfused placenta was investigated with the maternal circuit open and fetal circuit closed (recirculated). The fetal to maternal concentration ratio for D-leucine and antipyrine was 1.0, for L-leucine, 1.5, indicating a stereospecific transport mechanism for leucine. Cradients of 1.56 + 0.11 and 1.62 +. 0.10 were demonstrated for Lalanine and L-lysine, respectively. The establishment of transplacental gradients is a placental function, requiring no assistance using a variety of experimental techniques and experimental animals. Studies in the human have been extremely limited. Slices and fragments of human placenta have been used in vitro to measure amino acid transport (1 I, 12, 16, 19) , but the pertinence of the observations to transplacental transport is uncertain. Page et al. (13) have infused D-and L-histidine into several mothers shortly before delivery and have measured the relative concentrations of the stereoisomers in the cord blood at birth. They deduced that L-histidine was transferred more rapidly than the D-isomer. Gaull et al. (7) have studied transfer rates of the sulfur-amino acids during the second trimester in elective abortions.
For the past several years, we have been studying transplacental transport by perfusing a n isolated cotyledon of human placenta. Independent maternal and fetal circulations are established permitting the investigation of transfer in either direction. This technique has now been applied to the study of amino acid transport in a n attempt to answer such fundamental questions as the relation of exchange rates to net transfer, the pertinence of in vitro placental uptake studies to transplacental transport, the polarity of the placental membrane, and the possible reserve functions of the large intraplacental concentrations of amino acids. from maternal or fetal factors.
The ratios of the exchange rates for the L and D-isomers were MATERIALS AND METHODS determined as a measure of the active, stereospecific transport system. The L:D ratio from the maternal to fetal circulation for PERFUSION TECHNIQUE leucine was 1.64 f 0.19, for alanine 1.78 + 0.49. In the reverse ~h~ technique of dual perfusion of the human placental cotydirection, the ratio for leucine was 1.03. The placental membrane ledon has been published in detail (17) and, therefore, only a brief exhibits a polarity in active transport directed towards the fetus. description will be presented here. ~~~~h placentas obtained from The transplacental gradient for leucine is the result of a dynamic uncomplicated term gestations by either vaginal or abdominal equilibrium between active transport towards the fetus and diffu-deliveries are inspected on both sides and a suitable cotyledon is sion back towards the maternal circulation. identified. The artery and vein supplying the chorionic vascular The availability of intracellular amino acids to serve a s a reserve system are dissected and fine polyethylene catheters are inserted for fetal needs was studied perfusing the placenta with buffer and fixed by a 00 silk ligature. The perfusion of the fetal vascular containing no amino acids. After 2 hr of perfusion, 53-84% of each tree is started immediately with ~~~l~~~ buffered salt solution and of nine amino acids was still retained within the placenta. It is the perfused portion is isolated from the rest of the placenta. ~h~ suggested that the high tissue concentrations of amino acids are cotyledon is then turned upside down and ftwed in a perfusion related to the metabolic needs of the placenta rather than to its chamber filled with buffer solution. The decidual plate assumes a transport functions. white color over the area which is perfused from the fetal side indicating an efficient rinsing of the fetal capillaries. Two fine Speculation glass cannulas are inserted into the intervillous space by penetrating the decidual plate over the light colored area and the intervilThe Present studies have demonstrated differences between lous space is perfused through these cannulas. The perfusion phcental uptake and placental transfer of amino acids. It is still chamber, the two circuits and fluid reservoirs are mounted in a uncertain whether the two processes are serving two discrete temperature controlled box at 37O. Samples can be taken sepafunctions (placental nutrition and fetal nutrition) or whether trans-rately from maternal and fetal inflow as well as outflow. placental transfer involves mechanisms in addition to placental uptake (e.g., placental release).
ANALYTICAL METHODS
Antipyrine. The radioactive antipyrine was separated from the Amino acids circulating in maternal plasma are the primary radioactive amino acids by extracting I ml of perfusate with 2 ml substrates for the synthesis of proteins by the fetus (6) . Recent chloroform three times. The 6 ml of chloroform was evaporated studies suggest that they may also contribute to the energy supply to dryness under Nz in a scintillation vial and redissolved in 0.5 of the fetus (8) . The mechanisms by which the amino acids are ml H20. Diotol scintillant was added for determination of radiodelivered by the placenta to the fetus have been extensively studied activity.
Amino Acids. Nonradioactive amino acids were analyzed with a Phoenix Microanalyzer (model PKU). The samples were deproteinized with picric acid (20) . Two buffer systems were used: 0.2 M Na', 0.05 M citrate, titrated to pH 3.05 (8) for the elution of the acid, neutral, and branched-chain amino acids and 0.35 N Na+ buffer, at pH 4.68 for the aromatic and basic amino acids (18) . Lithium citrate buffer was used to achieve better separation of glutamic and aspartic acids and of their amides (2) .
Radioactive amino acids were identified by paper chromatography. Five ml perfusate was mixed with a n equal volume of 10% perchloric acid for deproteinization. After centrifugation, the pH of the supernatant was adjusted to 7.0 with KOH and again centrifuged. The supernatant was applied to Dowex 50 (H+), the resin was washed with water, and the amino acids eluted with 2 N NH,OH. The eluate was taken down to about 1 ml in a Buchner flash evaporator and then blown to dryness in a small centrifuge tube, under Np at 37'. The residue was dissolved in 50 pl water and submitted to paper chromatography in butano1:acetic acid: water (12:3:5). Standard amino acids were chromatographed concurrently and located by development with ninhydrinI~he parallel bands containing the radioactive amino acids were cut into small strips, and transferred to a scintillation vial and 3 ml .H20 added and the amino acids were eluted by shaking overnight in an incubator at 35'. The strips were removed and the water evaporated under Nz. The residue was redissolved in 0.5 ml H 2 0 and Diotol added. Radioactivity was determined on a two-channel (RH:14C) scintillation counter.
Radioactivity in perfused tissue was analyzed in the same fashion after extracting 5 g of tissue with 5 ml of 10% perchloric acid.
Nonlabeled amino acids were purchased from Schwartz-Mann, while radioactive amino acids and antipyrine (antipyrine-N-("H) methyl) were obtained from New England Nuclear, except for 14 C-D-glutamic acid which came from International Chemical and Nuclear Corp. All radioactive amino acids were uniformly labeled with either I4C or 'H and were tested for purity by paper chromatography.
RESULTS
The movement of amino acids across the perfused placental membrane is expressed as rates of transfer or rates of exchange. For the measurement of transfer rates, amino acids were added to only one perfusate, either maternal or fetal. The rate of transfer from maternal to fetal side was calculated from the amino acid concentration measured in the fetal vein and the flow-rate in the fetal perfusion circuit. In order to measure exchange rates, amino acids were added in equimolar concentration to both perfusates and radioactive labeled tracers were added to either maternal or fetal reservoir. The rate was calculated from the radioactivity measured in either maternal or fetal outflow and the respective flow-rate.
Transfer rates and exchange rates are generally presented as the percent of antipyrine transfer (clearance index or exchange index).
The rationale for this has been previously discussed (4) . In brief, by relating results to antipyrine transfer hemodynamic, anatomic, and technical variables are reduced permitting more reliable comparisons among experiments.
MAXIMAL TRANSFER RATES (DIFFUSION PLUS ACTIVE TRANSPORT)
Both maternal and fetal circulations were kept "open", that is, nor recirculated. Amino acids were added to the maternal perfusate in equimolar concentrations of 0.25 mM. N o amino acids were added to the fetal perfusate, thereby establishing a transplacental gradient towards the fetal circulation. The experiment lasted for approximately 60 min. Several 1 min samples were collected from the fetal outflow and the transfer rate was determined once steady state conditions had been achieved. Table I lists the results expressed as the percent of antipyrine transferred, which was measured in each experiment. Of the 15 amino acids that were studied, all except three had similar transfer rates averaging about a third of antipyrine. Aspartic acid, glutamic acid, and cystine were transferred at approximately half the rate of the others.
. .
EXCHANGE RATES
Equimolar concentrations of amino acids were added to the maternal and fetal perfusates, and trace amounts of radioactive amino acids and of radioactive antipyrine were added to the maternal perfusate. The rate of appearance of the radioactive amino acid in the fetal perfusate indicated the exchange rate. For the six amino acids that were studied by both techniques, the exchange index closely approximated the maximal transfer rate (clearance index) ( Table I B) .
T o provide a more accurate comparison, exchange and clearance indices for two amino acids, L-leucine and L-aspartic acid, were measured together in three experiments (Table 2 ). In the first phase of the perfusion, exchange rate was measured with amino acids in both maternal and fetal perfusates. In the second phase, amino acids were omitted from the fetal perfusate and the transfer rates were again measured. The results were very similar, with exchange being slightly higher than transfer rate in each study.
TRANSPLACENTAL AMINO ACID CONCENTRATION GRADIENTS
chromatography, the radioactive bands were eluted, and the L-leucine-I4C, D-leucine-", unlabeled L-and D-leucine, and antipyrine-"H were added in equal concentrations to the maternal and fetal perfusates. The maternal perfusate was not recirculated so that the concentration of the three constituents delivered to the placenta remained constant. The fetal circulation was closed. Samples were obtained at intervals for analysis.
Initially, the concentrations in the maternal and fetal circuits were the same (Fig. 1) . The concentration in the fetal perfusates fell rapidly, as compared to the maternal perfusate because of dilution with contents of the fetal vascular system. Antipyrine rapidly equilibrated across the placenta reestablishing a fetal: maternal ratio of one. D-leucine also reequilibrated to equal concentrations, but at a slower rate. L-leucine, after the initial fall in fetal concentration, rose more rapidly than D-leucine and established a gradient of 1.5.
Transplacental gradients of 1.56 + 0.1 1 and 1.62 + 0.10 were also established for L-alanine and L-lysine, respectively, in similar experiments.
STEREOSPECIFIC EXCHANGE RATES
L-and D-stereoisomers of leucine and alanine were added to maternal and fetal perfusates in equl concentration (0.1 mM). Trace amounts of each isomer, differentially labeled with either % or 14C, were added to the maternal perfusate. At the termination of the experiment, leucine and alanine were separated by paper Table 2 . Intraexperimental comparison of clearance and exchange index' %:l4C raGos'determined. The comparative exchange rates were calculated from the materna1:fetal ratios. The exchange rates for L-leucine and L-alanine were greater than for their stereoisomers, providing average L:D ratios of 1.64 and 1.78, respectively (Table  3) . In a similar study of exchange rates measured in the reverse direction, i.e., from the fetal perfusate, there was no difference between D-and L-leucine. At the end of each perfusion, the perfused cotyledon was extracted and analyzed in the same way as the perfusates. The concentration of L-alanine in the tissue was twice as high as Dalanine, but there was no difference in the concentrations of the isomers of leucine.
PLACENTAL CONTENT OF AMINO ACIDS
After perfusion of placenta for 2 hr with buffer containing no amino acids, the concentrations of amino acids in the perfused cotyledon were compared to those in an unperfused section of the placenta. In these studies, the greater proportion of amino acids was retained in the placenta (53-84%) after 2 hr of perfusion (Table 4) .
A series of six experiments was performed and the rate of appearance of amino acids in maternal and fetal perfusates was measured. The results for alanine are presented in Figure 2 . Similar results were obtained with glycine, taurine, aspartic acid, and glutamine. The concentration of amino acids eluted into the fetal perfusate falls rapidly during the first 30 min and then maintains a fairly constant rate for the rest of the experiment. Considerably more amino acid appears in the maternal perfusate and the rate of fall in concentration is more gradual. ' Concentrations of amino acids in placenta were determined after 2 hours of perfusion of both maternal and fetal compartments with buffer containing no amino acids. Results are compared with an aliquot of the same placenta that had not been perfused. Mean f SE of six placentas. parisons among experiments (4) . No-attempt has been made to translate the results into absolute transfer rates because the messages to be presented are dependent primarily on intra-and interexperimental comparisons.
L-leucine L-aspartic acid DISCUSSION
Equimolar concentrations of amino acids were added to perfusates to permit a more accurate comparison of transfer rates. In the first series of experiments, a downhill gradient was established towards the fetal circulation by adding the amino acids to only the maternal perfusate. Under these conditions, it can be assumed that transfer will be by diffusion as well as by active transport mechanisms. We have termed this the maximal transfer rate. The transfer rates expressed as the "clearance index" of 12 of the 15 amino acids that were studied were about the same (Table 1) . The three exceptions, aspartic acid, glutamic acid, and cystine were transferred at about half the rate of the others. From these observations, it is not possible to state whether the limitation in transfer of the three amino acids resulted from a reduction in diffusion rate, in active transport, or both. In vivo studies have shown a very slow transfer of cystine-cysteine across second trimester human placenta (7) . Aspartic acid and glutamic acid will be discussed more fully in a later paper.
Exchange rates for six of the amino acids were also determined by adding radioactive tracers to the maternal perfusate with equimolar concentrations of amino acids in both maternal and feial perfusates. The exchange indices approximated closely the results on transfer (Table I) indicating that exchange rates measure transfer under conditions in which diffusion as well as active transport can occur. When exchange rate and the maximal transport rate were compared within alternate phases of each experiment, it could be demonstrated that the former is actually slightly higher ( Table 2) . Acceleration of transfer when substrate is present on both sides of the membrane has been observed for the transfer of amino acids through other membranes. It is consistent with the model of a carrier that "shuttles" back and forth across the membrane, more efficiently when carrying substrate in both directions.
Studies of transport across membranes performed in vivo with isotopic tracers are almost always measurements of exchange rates because the substance under study is generally present on both siifes of the membrane. The usefulness of the information depends on the specifics of the physiologic and experimental situation. Diffusion rates of amino acids across the placenta is greater than the rates of active transport and, therefore, constitute a larger fraction of the exchange rate. However, placental transport towards the fetus in vivo is against a gradient eliminating diffusion as a mechanism. It is net transport that is the nutritionally significant figure and net transport is dependent solely on active transport.
T o investigate whether the perfusion system is suitable to study the active transport process, the establishment of gradients with select amino acids was investigated. The fetal circuit was closed and the equilibration of L-leucine, D-leucine, and antipyrine across the placental membrane was studied. Antipyrine equilibrated rapidly attaining a materna1:fetal ratio of one, as expected. Dleucine also equilibrated at equal concentrations, at a slower rate. L-leucine established a gradient (Fig. I) . Similar experiments with L-lysine and L-alanine also yielded the expected gradients toward the fetus.
These studies demonstrated that the perfusion system could be used to study active transport and that the establishment of transplacental gradients was a placental function that was not directly dependent on either maternal or fetal factors. It was also clear that active transport was stereospecific for the L-amino acid and that the D-isomer was transferred solely or primarily by diffusion processes. It then followed, logically, that the ratio of the transfer or exchange rates of the L-amino acid to D-amino acid, would provide a measure of active transport.
The reasoning is the same as that used by Page et al. (13) in their study of placental transfer of histidine in vivo. These investigators infused D-and L-histidine into a series of pregnant women at varying intervals before delivery in amounts that were sufficient to raise the maternal concentration of each isomer to approximately 3-5 mg%. The relative concentrations of the isomers were then determined in cord blood at the time of birth. L-histidine equilibrated across the placenta more rapidly than D-histidine indicating a more rapid rate of transfer. The perfusion technique offered several technical advantages over this approach. The stereoisomers could be differentially labeled with radioactive isotopes simplifying their identification and increasing the accuracy of the assays; the complicating features of maternal and fetal metabolism were eliminated; the circulations could be kept "open", i.e., the perfusates were not recirculated permitting multiple sampling with constant levels of the amino acids on both sides of the placenta so that relative transfer rates could be accurately determined; exchange rates in both directions across the placenta were measured.
A series of studies was undertaken comparing the exchange rates of the stereoisomers of leucine and alanine (Table 3 ). The ratios for the exchange rates towards the fetal circulation averaged 1.64 and 1.78, respectively. Similar studies in the reverse direction demonstrated no difference in exchange rates between D-and Lleucine. Active transport across the placenta appears to be unidirectional, towards the fetus. Transfer in the reverse direction occurs only by diffusion. Establishment of transplacental gradients for amino acids appears to be dependent on a dynamic equilibrium in which active transport towards the fetus is counterbalanced by diffusion pressure in the reverse direction. We have demonstrated comparable, though not as clearly interpretable, results using the in situ perfusion techniques of placenta in the guinea pig (5) .
Amino acid uptake by placental slices and fragments has been studied in this laboratory (16) and in others (I I, 12, 19) . Compar-ison of our results on transfer into the placenta with slices and the results on transfer through the placenta using the perfusion technique does not reveal any simple relation. Alanine is taken up from the incubation medium relatively rapidly by slices, developing an &fold intracellular gradient in an hour. In contrast, the intracellular concentration of leucine remained below that of the incubation medium because of a very rapid efflux rate (16) . In the present perfusion studies, alanine is also concentrated within the placenta more effectively than leucine (Table 3) . Despite these striking differences, the transfer rates and the transplacental gradients for the two amino acids were about the same.
We have suggested, based on observations in the guinea pig (5) , that placental transfer of amino acids across the placenta might involve an active uptake from the maternal circulation, concentration of the amino acids within the placenta, followed by passive release down a concentration gradient into the fetal circulation. The present observations suggest that the mechanism for transplacental transfer must be at least partly independent of the intraplacental concentration process to accommodate the major differences between alanine and leucine.
It has been speculated that the high concentration of amino acids in placenta may serve as a reserve, reducing the effect of changes in maternal serum levels on circulating levels in the fetus. The availability of placental amino acids for this purpose was investigated by perfusing placenta with buffer containing no amino acids. There was an immediate release of amino acids into the maternal and fetal perfusates (Fig. 2) . The rate of release and the amount released into the maternal circulation was greater than into the fetal circulation possibly because of the anatomic proximity to trophoblast. There were two phases to the rate at which amino acids appeared in the fetal perfusate. During the first 30 min, there was a rapidly falling rate followed by a slow sustained release for the remainder of the experiment. At the end of 2 hr perfusion, the greater proportion of the amino acids (53-84%) was still retained within the placenta (Table 4 ). The intracellular retention was, in fact, even greater than these figures imply because no correction was made for dilution by residual perfusate in intravascular and interstitial fluids. One must conclude that under the conditions of those studies the majority of placental amino acids are not freely available to the fetus.
It is more likely that the intracellular concentrations of amino acids are more closely related to its intrinsic metabolic requirements than to its transport functions. The placenta is an active metabolic organ with significant oxygen requirements (3) and involved in the synthesis of large amounts of protein. Similar amino acid concentrations have been reported in other active metabolic organs such as liver, brain, and muscle (1, 14, 15) .
